Latigo Biotherapeutics has secured $150m in a Series B financing round, which will be used to further the development of its ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...

Urethral syndrome causes spasms in the urethra, pain during urination, and the frequent urge to pee. Learn why treatment may ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Andrea McLean has revealed a worrying symptom she's grappling with following a severe bout of pneumonia. The former Loose ...

Lati­go Bio­ther­a­peu­tics thinks it can one-up Ver­tex Phar­ma­ceu­ti­cals’ re­cent­ly ap­proved Jour­navx, which ig­nit­ed the non-opi­oid land­scape for treat­ing pain.

Shoulder blade pain is commonly caused by a muscle strain but can also arise from rotator cuff tears, joint conditions like osteoarthritis, and acute shoulder injuries. In rare cases, the pain may ...

Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...

The American College of Physicians strongly recommends adding a triptan to an NSAID to treat adults with moderate to severe ...

ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients ...